Abstract

Recently it has become possible to de novo design high affinity protein binding proteins from target structural information alone. There is, however, considerable room for improvement as the overall design success rate is low. Here, we explore the augmentation of energy-based protein binder design using deep learning. We find that using AlphaFold2 or RoseTTAFold to assess the probability that a designed sequence adopts the designed monomer structure, and the probability that this structure binds the target as designed, increases design success rates nearly 10-fold. We find further that sequence design using ProteinMPNN rather than Rosetta considerably increases computational efficiency.

Recently, a pipeline for the design of protein-binding proteins using only the structure of the target protein was reported. Here, the authors report that the incorporation of deep learning methods into the original pipeline increases experimental success rate by ten-fold.

Details

Title
Improving de novo protein binder design with deep learning
Author
Bennett, Nathaniel R. 1   VIAFID ORCID Logo  ; Coventry, Brian 2 ; Goreshnik, Inna 3 ; Huang, Buwei 4 ; Allen, Aza 3   VIAFID ORCID Logo  ; Vafeados, Dionne 3   VIAFID ORCID Logo  ; Peng, Ying Po 3 ; Dauparas, Justas 3   VIAFID ORCID Logo  ; Baek, Minkyung 3   VIAFID ORCID Logo  ; Stewart, Lance 3   VIAFID ORCID Logo  ; DiMaio, Frank 3 ; De Munck, Steven 5   VIAFID ORCID Logo  ; Savvides, Savvas N. 5   VIAFID ORCID Logo  ; Baker, David 2   VIAFID ORCID Logo 

 University of Washington, Department of Biochemistry, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Institute for Protein Design, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Molecular Engineering Graduate Program, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington, Department of Biochemistry, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Institute for Protein Design, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Howard Hughes Medical Institute, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington, Department of Biochemistry, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Institute for Protein Design, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington, Department of Biochemistry, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Institute for Protein Design, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Department of Bioengineering, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 VIB-UGent Center for Inflammation Research, Ghent, Belgium (GRID:grid.510970.a); Ghent University, Unit for Structural Biology, Department of Biochemistry and Microbiology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798) 
Pages
2625
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2810253824
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.